Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody-Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse-Reference-Cited by-同舟云学术

Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody-Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse

Published:2001-11 Issue:11 Volume:41 Page:1206-1214
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Dowell James A.,Korth-Bradley Joan,Liu Hanjiu,King S. Peter,Berger Mark S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

1. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells;Griffin;Leukemia Research,1984

2. Calicheamicins, a novel family of antitumor antibiotics: 1. Chemistry and partial characterization of 1I;Lee;J Am Chem Soc,1987

3. Interaction of Calicheamicin with DNA

4. Calicheamicin 1I and DNA: molecular recognition process responsible for site-specificity;Zein;Science,1989

5. Specific abstraction of the 5′(S)- and 4′-deoxyribosyl hydrogen atoms from DNA by calicheamicin γ1I;Hangeland;J Am Chem Soc,1992

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08

2. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

3. Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload;Xenobiotica;2024-07-17

4. Trastuzumab-deruxtecan in solid tumors with HER2 alterations: from early phase development to the first agnostic approval of an antibody–drug conjugate;Expert Opinion on Investigational Drugs;2024-07-09

5. Antibody-drug conjugates: A review of cutaneous adverse effects;Journal of the American Academy of Dermatology;2024-07